Cargando…
The triple helix: 50 years later, the outcome
Triplex-forming oligonucleotides constitute an interesting DNA sequence-specific tool that can be used to target cleaving or cross-linking agents, transcription factors or nucleases to a chosen site on the DNA. They are not only used as biotechnological tools but also to induce modifications on DNA...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2532714/ https://www.ncbi.nlm.nih.gov/pubmed/18676453 http://dx.doi.org/10.1093/nar/gkn493 |
_version_ | 1782158991661465600 |
---|---|
author | Duca, Maria Vekhoff, Pierre Oussedik, Kahina Halby, Ludovic Arimondo, Paola B. |
author_facet | Duca, Maria Vekhoff, Pierre Oussedik, Kahina Halby, Ludovic Arimondo, Paola B. |
author_sort | Duca, Maria |
collection | PubMed |
description | Triplex-forming oligonucleotides constitute an interesting DNA sequence-specific tool that can be used to target cleaving or cross-linking agents, transcription factors or nucleases to a chosen site on the DNA. They are not only used as biotechnological tools but also to induce modifications on DNA with the aim to control gene expression, such as by site-directed mutagenesis or DNA recombination. Here, we report the state of art of the triplex-based anti-gene strategy 50 years after the discovery of such a structure, and we show the importance of the actual applications and the main challenges that we still have ahead of us. |
format | Text |
id | pubmed-2532714 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-25327142008-09-16 The triple helix: 50 years later, the outcome Duca, Maria Vekhoff, Pierre Oussedik, Kahina Halby, Ludovic Arimondo, Paola B. Nucleic Acids Res Survey and Summary Triplex-forming oligonucleotides constitute an interesting DNA sequence-specific tool that can be used to target cleaving or cross-linking agents, transcription factors or nucleases to a chosen site on the DNA. They are not only used as biotechnological tools but also to induce modifications on DNA with the aim to control gene expression, such as by site-directed mutagenesis or DNA recombination. Here, we report the state of art of the triplex-based anti-gene strategy 50 years after the discovery of such a structure, and we show the importance of the actual applications and the main challenges that we still have ahead of us. Oxford University Press 2008-09 2008-08-01 /pmc/articles/PMC2532714/ /pubmed/18676453 http://dx.doi.org/10.1093/nar/gkn493 Text en © 2008 The Author(s) http://creativecommons.org/licenses/by-nc/2.0/uk/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Survey and Summary Duca, Maria Vekhoff, Pierre Oussedik, Kahina Halby, Ludovic Arimondo, Paola B. The triple helix: 50 years later, the outcome |
title | The triple helix: 50 years later, the outcome |
title_full | The triple helix: 50 years later, the outcome |
title_fullStr | The triple helix: 50 years later, the outcome |
title_full_unstemmed | The triple helix: 50 years later, the outcome |
title_short | The triple helix: 50 years later, the outcome |
title_sort | triple helix: 50 years later, the outcome |
topic | Survey and Summary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2532714/ https://www.ncbi.nlm.nih.gov/pubmed/18676453 http://dx.doi.org/10.1093/nar/gkn493 |
work_keys_str_mv | AT ducamaria thetriplehelix50yearslatertheoutcome AT vekhoffpierre thetriplehelix50yearslatertheoutcome AT oussedikkahina thetriplehelix50yearslatertheoutcome AT halbyludovic thetriplehelix50yearslatertheoutcome AT arimondopaolab thetriplehelix50yearslatertheoutcome AT ducamaria triplehelix50yearslatertheoutcome AT vekhoffpierre triplehelix50yearslatertheoutcome AT oussedikkahina triplehelix50yearslatertheoutcome AT halbyludovic triplehelix50yearslatertheoutcome AT arimondopaolab triplehelix50yearslatertheoutcome |